Blue Cross Blue Shield of North Carolina (BCBSNC) is sending three separate letters to physicians about changes in the administrative process related to selected hypnotic agents, selective serotonin reuptake inhibitors, and certain triptan products. Effective April 1, 2010, these drugs will be considered restricted access drugs that will require a physician to provide a written certification to BCBSNC prior to the drug being covered by a BCBSNC member’s prescription drug benefits.
BCBSNC Announces Changes Regarding Restricted-Access Drugs
More Posts in Bulletins
Share this Post